Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Adaptimmune Therapeutics PLC ADR sell nvestor

Adaptimmune Therapeutics PLC ADR
Start price
€9.05
30.05.20 / 50%
Target price
€4.00
18.10.20
Performance (%)
-37.02%
End price
€5.70
18.10.20
Summary
This prediction ended on 18.10.20 with a price of €5.70. The SELL prediction by nvestor for Adaptimmune Therapeutics PLC ADR performed very well with a performance of -37.02%. nvestor has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Adaptimmune Therapeutics PLC ADR 9.290% 9.290% -20.635% -78.632%
iShares Core DAX® 2.594% -1.861% 13.242% 16.867%
iShares Nasdaq 100 3.553% -2.064% 38.293% 45.898%
iShares Nikkei 225® 0.687% -8.704% 17.510% 2.760%
iShares S&P 500 2.209% -1.988% 27.632% 42.955%

According to nvestor what are the pros and cons of Adaptimmune Therapeutics PLC ADR for the foreseeable future?

Pros
Cons
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Bad rating
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Bad culture
Little innovation
Few uniques
Dependend from some customers or products
Below average Marketposition
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Low dividend yield expected
negative Cash Flow expected
Little Investments for future growth
Risky balance sheet
Below average Management
Growths slower than the competition
Sustainability is little important
high free float
Higher risks for its business
Significant cyclical dependencies
Little known brand
Business model of the past or high risk

Comments by nvestor for this prediction

In the thread Adaptimmune Therapeutics PLC ADR diskutieren
Prediction Sell
Perf. (%) -37.02%
Target price 4.000
Change
Ends at 18.10.20

Sell mit Kursziel 4,0

nvestor 
0
Report Share
30.05.20
In the thread Trading Adaptimmune Therapeutics PLC ADR
Prediction Sell
Perf. (%) -37.02%
Target price 4.000
Change
Ends at 18.10.20

Sell beendet

nvestor 
0
Report Share
18.10.20

Stopped prediction by nvestor for Adaptimmune Therapeutics PLC ADR

sell
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.07
13.04.24
€1.00
13.04.25
-6.54%
27.04.24

Probably not worthwhile Investment
Lower EBIT Margin than peer group
Bad rating
ROE lower than 10% per year
nvestor 
13.04.24 50%